The University of Chicago Header Logo

Connection

Daniel Arber to Antigens, CD34

This is a "connection" page, showing publications Daniel Arber has written about Antigens, CD34.
Connection Strength

0.747
  1. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms. Am J Clin Pathol. 2014 May; 141(5):656-64.
    View in: PubMed
    Score: 0.455
  2. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Am J Clin Pathol. 1997 Apr; 107(4):430-7.
    View in: PubMed
    Score: 0.139
  3. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations. Am J Clin Pathol. 2002 Feb; 117(2):306-13.
    View in: PubMed
    Score: 0.049
  4. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996 Oct; 106(4):462-8.
    View in: PubMed
    Score: 0.034
  5. Vimentin-negative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34. Am J Surg Pathol. 1993 Mar; 17(3):302-7.
    View in: PubMed
    Score: 0.026
  6. Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. Br J Haematol. 2009 Jun; 146(1):86-90.
    View in: PubMed
    Score: 0.020
  7. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003 Jun 15; 101(12):4701-7.
    View in: PubMed
    Score: 0.013
  8. Large solitary fibrous tumor of the kidney: report of two cases and review of the literature. Am J Surg Pathol. 2001 Sep; 25(9):1194-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.